October 2018
Volume 13 Issue 10 |
|
|
|
|
advertisement
 |
|
Features
The risks of microbial contamination inherent in the production of viral vaccines and viral vectors used in biotherapeutic applications must be addressed.
/ read more /
This article discusses the retiring of Ph. Eur. and USP heavy metal assays as well as a means of updating related specifications with minimal regulatory burden.
/ read more /
|
|
|
Subscribe
Subscribers can enjoy each full issue of Pharmaceutical Technology in print or via the PharmTech app.
subscription offers |
 |
|
|
|
advertisement
 |
|
News
The companies collaborated to launch a new cell-based profiling service for biochemical assay.
/ read more /
Research suggests that LumaCyte's Radiance instrument offers the ability to rapidly analyze viral vaccines to speed development and production and ensure their effectiveness.
/ read more /
Lonza's new PyroTec Pro Robotic Solution provides a fully automated workflow for endotoxin detection.
/ read more /
The pharmaceutical, clinical, and bioanalytical contract solutions provider has implemented advanced techniques for the collection and use of peripheral blood mononuclear cells (PBMCs) for early-phase clinical trials at its Clinical Pharmacology Unit in Antwerp, Belgium.
/ read more /
|
|
|
New Technology
Lonza's Capsugel Colorista capsule R&D solution can cut overall development time and offers greater flexibility during technical color development.
/ read more /
Mettler Toledo's XSR Analytical Balances help simplify laboratory workflows and enable convenient and ergonomic balance operation while delivering high-weighing accuracy.
/ read more /
New software tools by Tecan, a provider of automated laboratory instruments and solutions, complement each other to enhance process monitoring of its liquid-handling platforms.
/ read more /
The companies have partnered to launch Conjugated Polymer Nanoparticle (CPN) products for use in molecular imaging and R&D applications.
/ read more /
|
|
|
|
|
